ECSP23017767A - PHYTOTHERAPEUTIC COMPOSITION - Google Patents
PHYTOTHERAPEUTIC COMPOSITIONInfo
- Publication number
- ECSP23017767A ECSP23017767A ECSENADI202317767A ECDI202317767A ECSP23017767A EC SP23017767 A ECSP23017767 A EC SP23017767A EC SENADI202317767 A ECSENADI202317767 A EC SENADI202317767A EC DI202317767 A ECDI202317767 A EC DI202317767A EC SP23017767 A ECSP23017767 A EC SP23017767A
- Authority
- EC
- Ecuador
- Prior art keywords
- liquid
- species
- phytotherapeutic composition
- phytotherapeutic
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000007788 liquid Substances 0.000 abstract 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract 1
- 240000002234 Allium sativum Species 0.000 abstract 1
- 208000025721 COVID-19 Diseases 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 241000208125 Nicotiana Species 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 229960002715 nicotine Drugs 0.000 abstract 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
- 239000001841 zingiber officinale Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Una composición fitoterapéutica, para el tratamiento de Covid-19 y otras infecciones virales, que comprende partes que contienen nicotina de una especie del género Nicotiana, opcionalmente en combinación con una o más de las especies Allium sativum, Zingiber officinale y Curcuma longa, en forma de formulación nasal líquida, oral líquida u ocular líquida.A phytotherapeutic composition, for the treatment of Covid-19 and other viral infections, comprising nicotine-containing parts of a species of the genus Nicotiana, optionally in combination with one or more of the species Allium sativum, Zingiber officinale and Curcuma longa, in the form liquid nasal, liquid oral or liquid eye formulation.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2013130.6A GB2598160A (en) | 2020-08-21 | 2020-08-21 | Phytotherapeutic composition |
| GBGB2100710.9A GB202100710D0 (en) | 2021-01-19 | 2021-01-19 | Phytotherapeutic composition |
| IB2022038472 | 2022-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP23017767A true ECSP23017767A (en) | 2023-04-28 |
Family
ID=86745340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSENADI202317767A ECSP23017767A (en) | 2020-08-21 | 2023-03-10 | PHYTOTHERAPEUTIC COMPOSITION |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP23017767A (en) |
-
2023
- 2023-03-10 EC ECSENADI202317767A patent/ECSP23017767A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20220035A1 (en) | STABILITY CHARACTERISTICS IN A WEAR MEMBERS ASSEMBLY | |
| MX2022007908A (en) | PHARMACEUTICAL COMBINATION OF A THERAPEUTIC OLIGONUCLEOTIDE THAT ACTS ON HBV AND A TLR7 AGONIST FOR THE TREATMENT OF HBV. | |
| EA201300897A1 (en) | ANTI-MICROBIAL COMPOSITION | |
| CO2018014229A2 (en) | Biopesticide composition for use in prevention or minimization of plant disease | |
| CO2021004681A2 (en) | Use of reboxetine for the treatment of narcolepsy | |
| CL2019002218A1 (en) | Triple combination formulations and methods to treat or reduce the risk of cardiovascular disease. | |
| MX2024010236A (en) | Akkermansia for preventing and/or treating reward dysregulation disorders | |
| CO2023001417A2 (en) | Phytotherapeutic composition | |
| CO2021017724A2 (en) | Melanoidin compositions for protecting crops from non-fungal pests | |
| DOP2023000084A (en) | SOLID FORMULATION | |
| MX2021006654A (en) | Use of cocculus hirsutus extract for treating dengue. | |
| AR127494A1 (en) | AGROCHEMICAL FORMULATION OF MICRONIZED WAX AND SILICONE | |
| CO2021006031A2 (en) | Powdered botanical extract preparations and formulations thereof | |
| ECSP19006687A (en) | COMBINATION OF A BCL-2 INHIBITOR AND A MCL-1 INHIBITOR, USES AND PHARMACEUTICAL COMPOSITIONS | |
| MX2020008511A (en) | THIXOTROPIC ANTIMICROBIAL COMPOSITION. | |
| MX2024007944A (en) | 4-PHENYL-TETRAHYDROPYRIDINE DERIVATIVES FOR THE TREATMENT OF HEARING DISEASES. | |
| CL2022000095A1 (en) | Pharmaceutical compositions resistant to the discharge of doses that comprise venirunad | |
| PY2258178A (en) | FUNGICIDE USE | |
| CO2023001421A2 (en) | Pharmaceutical composition to prevent or treat viral infections | |
| PL426616A1 (en) | Dietary supplement | |
| DE602004022306D1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING PLANT MATERIALS FROM TRICHILIA SPP. ONLY OR IN CONNECTION WITH OTHER PLANT EXTRACTS FOR THE TREATMENT AND / OR PREVENTION OF HEART CHAMBER FLAVORS | |
| BR112021016808A2 (en) | Herbal drug compositions for the treatment of dengue and their production | |
| MX367243B (en) | Composition of plant extracts that increase díderlein's bacilli, used for the treatment of sexually transmitted diseases (std) and the human papillomavirus (hpv), having an aphrodisiac effect. | |
| AR120453A1 (en) | COMBINATION OF A BTK INHIBITOR AND AN MDM2 INHIBITOR FOR THE TREATMENT OF CANCER | |
| BR112017026422A2 (en) | Use of a combination of curcuma longa, punica granatum and zingiber officinale extracts in the prevention and/or treatment of mucosal lesions |